Galbraith Kenneth - Insider Non-Derivative Transactions at Zymeworks Inc. (ZYME) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 22, 2025, Galbraith Kenneth's relationship to Zymeworks Inc. (ZYME) is Director,Officer (Chair & CEO), and currently has 180,803 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ZYME insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Galbraith Kenneth - Insider Non-Derivative Transactions of ZYME Common Stock

Galbraith Kenneth - Insider Non-Derivative Transactions at ZYME

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 23, 2025	Sell -- (Common Stock)	47528	27.02	133275
Dec 23, 2025	M -- (Common Stock)	100000	0	180803
Jan 7, 2025	Sell -- (Common Stock)	23885	14.92	47543
Jan 7, 2025	M -- (Common Stock)	47666	0	71428
Jan 7, 2025	Sell -- (Common Stock)	33406	14.92	80803
Jan 7, 2025	M -- (Common Stock)	66666	0	114209
Jan 9, 2024	Sell -- (Common Stock)	5706	11.22	23762
Jan 6, 2024	Sell -- (Common Stock)	18198	10.65	29468
Jan 6, 2024	M -- (Common Stock)	47666	0	47666